Dr Michael C Malinics, DO | |
4040 Highway 17 Unit 202, Murrells Inlet, SC 29576-5098 | |
(843) 235-3131 | |
(203) 709-5545 |
Full Name | Dr Michael C Malinics |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 38 Years |
Location | 4040 Highway 17 Unit 202, Murrells Inlet, South Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255499653 | NPI | - | NPPES |
001002394 | Medicaid | CT | |
020239-7359 | Other | CT | CONNECTICARE |
040000239CT08 | Other | CT | ANTHEM BCBS CT |
1255499653 | Medicaid | CT | |
415474 | Other | CT | WELLCARE |
P3837931 | Other | CT | OXFORD |
4250662 | Other | CT | AETNA |
1086984 | Other | CT | USA |
21-50233 | Other | CT | UHC |
P00453279 | Other | CT | RR MEDICARE |
21-50233 | Other | CT | AMERICHOICE |
2V9983 | Other | CT | HEALTHNET/COMMERCIAL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 000239 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Mary's Hospital | Waterbury, CT | Hospital |
St Francis Hospital & Medical Center | Hartford, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Trinity Health Of New England Provider Network Organization Inc | 0941113567 | 621 |
News Archive
Schering-Plough Corporation today announced it has initiated sponsorship of two projects in India to reduce the incidence of human and animal rabies through improved educational awareness and mass vaccination of dogs. The company will donate $200,000 and rabies vaccine from Intervet/Schering-Plough as well as share expertise with partners to support successful implementation of the projects in ten villages surrounding Bangalore and Pune, India.
AbSorber strengthen its position on the important US market by acquiring NorDiag's share of Olerup Inc. AbSorber buys the company together with SSP Primers and after the transition will AbSorber own 50 percent of Olerup Inc. and SSP Primers 50 percent.
Advances in brain imaging can identify a greater number of stroke patients who can receive therapy later than previously believed, according to a new study.
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
› Verified 3 days ago
Entity Name | Trinity Health Of New England Provider Network Organization Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003882812 PECOS PAC ID: 0941113567 Enrollment ID: O20031110000651 |
News Archive
Schering-Plough Corporation today announced it has initiated sponsorship of two projects in India to reduce the incidence of human and animal rabies through improved educational awareness and mass vaccination of dogs. The company will donate $200,000 and rabies vaccine from Intervet/Schering-Plough as well as share expertise with partners to support successful implementation of the projects in ten villages surrounding Bangalore and Pune, India.
AbSorber strengthen its position on the important US market by acquiring NorDiag's share of Olerup Inc. AbSorber buys the company together with SSP Primers and after the transition will AbSorber own 50 percent of Olerup Inc. and SSP Primers 50 percent.
Advances in brain imaging can identify a greater number of stroke patients who can receive therapy later than previously believed, according to a new study.
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael C Malinics, DO Po Box 421718, Georgetown, SC 29442-4203 Ph: (843) 652-8226 | Dr Michael C Malinics, DO 4040 Highway 17 Unit 202, Murrells Inlet, SC 29576-5098 Ph: (843) 235-3131 |
News Archive
Schering-Plough Corporation today announced it has initiated sponsorship of two projects in India to reduce the incidence of human and animal rabies through improved educational awareness and mass vaccination of dogs. The company will donate $200,000 and rabies vaccine from Intervet/Schering-Plough as well as share expertise with partners to support successful implementation of the projects in ten villages surrounding Bangalore and Pune, India.
AbSorber strengthen its position on the important US market by acquiring NorDiag's share of Olerup Inc. AbSorber buys the company together with SSP Primers and after the transition will AbSorber own 50 percent of Olerup Inc. and SSP Primers 50 percent.
Advances in brain imaging can identify a greater number of stroke patients who can receive therapy later than previously believed, according to a new study.
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
› Verified 3 days ago
Stephen Alan Silbiger, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4630 Highway 17, Murrells Inlet, SC 29576 Phone: 843-235-8333 Fax: 843-606-8087 | |
Kristin Etzkorn, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4835 Highway 17, Murrells Inlet, SC 29576 Phone: 843-357-1021 | |
Dr. Ivo V. Anguelov, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4914 Highway 17, Murrells Inlet, SC 29576 Phone: 843-357-6734 Fax: 843-357-6770 | |
Dr. Dora L. Anguelova, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4914 Highway 17, Murrells Inlet, SC 29576 Phone: 843-357-6734 Fax: 843-357-6770 | |
Dr. Michael Edward Haughton, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4181 Highway 17, Murrells Inlet, SC 29576 Phone: 843-652-3600 Fax: 843-652-3602 | |
Dr. Joshua Bernard Coney, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4040 Highway 17 Unit 202, Murrells Inlet, SC 29576 Phone: 843-237-3131 |